Cargando…
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines
The optimal vaccination strategy to boost responses in the context of pre-existing immune memory to the SARS-CoV-2 spike (S) glycoprotein is an important question for global public health. To address this, we explored the SARS-CoV-2-specific humoral and cellular immune responses to a novel self-ampl...
Autores principales: | Elliott, Tamara, Cheeseman, Hannah M., Evans, Abbey B., Day, Suzanne, McFarlane, Leon R., O’Hara, Jessica, Kalyan, Mohini, Amini, Fahimah, Cole, Tom, Winston, Alan, Fidler, Sarah, Pollock, Katrina M., Harker, James A., Shattock, Robin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565686/ https://www.ncbi.nlm.nih.gov/pubmed/36194628 http://dx.doi.org/10.1371/journal.ppat.1010885 |
Ejemplares similares
-
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2
por: Szubert, Alex J., et al.
Publicado: (2023) -
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial
por: Pollock, Katrina M., et al.
Publicado: (2022) -
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
por: Spencer, Alexandra J., et al.
Publicado: (2021) -
Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines
por: Tregoning, John S., et al.
Publicado: (2022) -
Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines
por: Blakney, Anna K., et al.
Publicado: (2021)